Header cover image

Global Pharmaceuticals & Biotech Defensive Stocks

UPDATED Jun 29, 2022

Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.

100 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
2M7CChina Medical System HoldingsHK$1.440.7%-34.5%HK$29.8bHK$2.00PE8.4xE8.0%4.7%
CHSY.FChina Medical System HoldingsHK$1.590%n/aHK$29.8bHK$2.21PE8.4xE8.0%4.7%
867China Medical System HoldingsHK$12.502.8%-38.9%HK$30.7bHK$16.89PE8.7xE8.0%4.6%
867China Medical System HoldingsHK$12.502.8%-38.9%HK$30.7bHK$16.89PE8.7xE8.0%4.6%
867China Medical System HoldingsHK$12.160%-40.5%HK$29.8bHK$16.89PE8.4xE8.0%4.7%
NOVNNovartisCHF81.193.3%-3.7%CHF176.3bCHF90.68PE7.6xE2.7%3.6%
SQURPHARMASquare Pharmaceuticals৳218.001.4%1.2%৳193.2b৳320.40PE10.4xE11.6%2.8%
NOTANovartisCHF81.205.7%5.7%CHF176.2bCHF90.75PE7.6xE2.7%3.6%
NVSE.FNovartisCHF84.857.7%-7.8%CHF176.3bCHF94.77PE7.6xE2.7%3.6%
NVSNovartisCHF84.774.0%-7.1%CHF176.3bCHF94.68PE7.6xE2.7%3.6%
NOVNEENovartisCHF81.203.3%-5.0%CHF176.3bCHF90.70PE7.6xE2.7%3.6%
600332Guangzhou Baiyunshan Pharmaceutical HoldingsHK$31.231.8%-7.7%HK$56.4bHK$31.74PE8.2xE8.9%3.5%
GU5Guangzhou Baiyunshan Pharmaceutical HoldingsHK$2.683.1%6.3%HK$55.4bHK$2.76PE8.1xE8.9%3.5%
999China Resources Sanjiu Medical & PharmaceuticalCN¥43.44-2.4%62.4%CN¥42.9bCN¥49.17PE19.1xE13.2%2.0%
2287Tibet Cheezheng Tibetan MedicineCN¥26.06-1.1%-3.4%CN¥13.8bn/aPE19.7xn/a2.3%
15303SBioHK$6.450.9%-32.8%HK$15.7bHK$8.34PE8.1xE6.9%3.1%
IPNIpsen€89.354.7%1.9%€7.4b€102.50PE11.4xE0.7%1.3%
83B3SBioHK$0.774.1%-24.3%HK$15.7bn/aPE8.1xE6.9%3.1%
I7GIpsen€85.504.7%-2.5%€7.0b€102.74PE10.9xE0.7%1.4%
NVS NNovartisCHF1,639.260%-9.9%CHF176.3bCHF1,830.91PE7.6xE2.7%3.6%
15303SBioHK$6.664.2%-30.6%HK$16.2bHK$8.34PE8.4xE6.9%3.0%
NVSNovartisCHF5,345.009.1%36.2%CHF176.3bCHF5,970.05PE7.6xE2.7%3.6%
999China Resources Sanjiu Medical & PharmaceuticalCN¥45.001.4%60.1%CN¥43.0bCN¥49.17PE19.8xE13.2%1.9%
2287Tibet Cheezheng Tibetan MedicineCN¥25.75-1.3%-9.4%CN¥13.5bn/aPE19.4xn/a2.3%
Page 1 of 5